Irritable Bowel Syndrome News and Research

Latest Irritable Bowel Syndrome News and Research

NIH panel proposes multiple management strategies for lactose intolerant individuals

NIH panel proposes multiple management strategies for lactose intolerant individuals

Enrollment complete in Ocera Therapeutics' ASTUTE Phase 2B trial for mild hepatic encephalopathy

Enrollment complete in Ocera Therapeutics' ASTUTE Phase 2B trial for mild hepatic encephalopathy

Lexicon Pharmaceuticals reports positive results from Phase 2 clinical trials for IBS and type 2 diabetes

Lexicon Pharmaceuticals reports positive results from Phase 2 clinical trials for IBS and type 2 diabetes

Tioga Pharmaceuticals to utilize $18M equity funding for Phase 3 clinical trial of asimadoline

Tioga Pharmaceuticals to utilize $18M equity funding for Phase 3 clinical trial of asimadoline

Ironwood Pharmaceuticals' IPO: Underwriters exercise over-allotment option

Ironwood Pharmaceuticals' IPO: Underwriters exercise over-allotment option

Exagen Diagnostics, EndoChoice announce agreement for promoting diagnostic services to U.S. gastroenterologists

Exagen Diagnostics, EndoChoice announce agreement for promoting diagnostic services to U.S. gastroenterologists

TI commences Phase IIa clinical trial for its lead molecule in CDH

TI commences Phase IIa clinical trial for its lead molecule in CDH

New research may help adopt acupuncture as a treatment option for NHS patients

New research may help adopt acupuncture as a treatment option for NHS patients

Quintiles announces strategic alliance with Movetis NV for commercialization of Resolor

Quintiles announces strategic alliance with Movetis NV for commercialization of Resolor

DNA variations in genes increase risk of developing PI-IBS

DNA variations in genes increase risk of developing PI-IBS

Lexicon Pharmaceuticals reports positive results from its LX4211 Phase 2 trial in type 2 diabetic patients

Lexicon Pharmaceuticals reports positive results from its LX4211 Phase 2 trial in type 2 diabetic patients

Over-the-counter medications can help manage minor ailments

Over-the-counter medications can help manage minor ailments

Alterations in intestinal microbiota may lie behind IBS aetiology

Alterations in intestinal microbiota may lie behind IBS aetiology

Findings suggest abuse is a risk factor for chronic headache

Findings suggest abuse is a risk factor for chronic headache

St. John's wort not effective in treating IBS

St. John's wort not effective in treating IBS

Neurocrine to advance its NBI-98854 VMAT2 Inhibitor into a multiple repeated dose Phase 1 study

Neurocrine to advance its NBI-98854 VMAT2 Inhibitor into a multiple repeated dose Phase 1 study

Immuno Laboratories and TRPN sign agreement to reduce chronic illness

Immuno Laboratories and TRPN sign agreement to reduce chronic illness

Neurocrine Biosciences to sell 4,784,689 shares of common stock to Venrock affiliates

Neurocrine Biosciences to sell 4,784,689 shares of common stock to Venrock affiliates

Drop in U.S. colorectal cancer deaths

Drop in U.S. colorectal cancer deaths

Salix Pharmaceuticals discusses proposed rifaximin NDA with the FDA

Salix Pharmaceuticals discusses proposed rifaximin NDA with the FDA